Skip to contentV
Vycor Medical Inc
V
VYCOVycor Medical Inc Q2 2023 · 10-Q
Revenue$482.77K$482.77K+47.2% vs Q2 2022 Net Income$68.41K$68.41KN/M vs Q2 2022 EPS Diluted$0.00$0.00— vs Q2 2022 Gross Profit$442,971+47.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
Operating Cash Flowderived$13,330N/M Margins · derivedGross margin91.8%+0.3 pt vs Q2 2022
Operating margin20.0%+42.7 pt vs Q2 2022
Net margin14.2%+44.4 pt vs Q2 2022
ended Jun 30, 2023 · filed Aug 11, 2023 · 42 d after period end